⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29218330 | 0.79 | — | — | |
| SCHEMBL22639055 | 0.73 | — | — | |
| SCHEMBL9309968 | 0.71 | TSHR (0.43) | — | |
| SCHEMBL30069192 | 0.71 | — | — | |
| SCHEMBL600724 | 0.71 | — | — | |
| SCHEMBL22084929 | 0.69 | MAOB (0.48) | — | |
| SCHEMBL5096058 | 0.68 | IDH1 (0.44) | — | |
| SCHEMBL16347475 | 0.68 | ALDH1A1 (0.40) | — | |
| SCHEMBL25338486 | 0.67 | TSHR (0.36) | — | |
| SCHEMBL16148655 | 0.67 | ACHE (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0431371-B1 | 3-Aminopyrroles, process for their preparation and their use as anticonvulsives | DRESDEN ARZNEIMITTEL (DE) | 1997-09-10 | — | — | EP | claimed |
| EP-1753724-A1 | HETEROCYCLIC DERIVATIVES FOR TREATMENT OF HYPERLIPIDEMIA AND RELATED DISEASES | AVANIR PHARMACEUTICALS (US) | 2007-02-21 | — | — | EP | disclosed |
| WO-2005123686-A1 | HETEROCYCLIC DERIVATIVES FOR TREATMENT OF HYPERLIPIDEMIA AND RELATED DISEASES | AVANIR PHARMACEUTICALS (US) | 2005-12-29 | — | — | WO | disclosed |
| US-5684160-A | 3-aminopyrroles, methods for their synthesis and for their pharmaceutical use | ARZNEIMETTELWERK DRESDEN GMBH (DE) | 1997-11-04 | — | — | US | disclosed |
| US-5502051-A | CENTRAL NERVOUS SYSTEM, ANTISPASMODIC | ARZNEIMITTELWERK DRESDEN GMBH (DE) | 1996-03-26 | — | — | US | disclosed |